Related Experiment Video
Updated: Apr 18, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Cardioprotective cryptides derived from fish and other food sources: generation, application, and future markets
1Instituto de Agroquı́mica y Tecnologı́a de Alimentos (CSIC), Avenida Agustín Escardino 7, 46980 Paterna, Valencia, Spain.
Abstract:
The primary function of dietary protein is to provide amino acids for protein synthesis. However, protein is also a source of latent bioactive peptides or cryptides with potential health benefits including the control and regulation of blood pressure. Hypertension or high blood pressure is one of the major, controllable risk factors in the development of cardiovascular disease (CVD), and it is also implicated in the development of myocardial infarction, heart failure, and end-stage diabetes. Cryptides can act on various systems of the body including the circulatory, gastrointestinal (GI), nervous, skeletal, and respiratory systems. A number of studies carried out to date have examined the health benefits of food protein isolates and hydrolysates. This review provides an overview of existing blood pressure regulating peptides and products derived from fish and other protein sources and hydrolysates. It discusses the methods used currently to generate and identify cryptides from these sources and their application in food and pharmaceutical products. It also looks at the current market for protein-derived peptides and peptide-containing products, legislation governing their use, and the future development of research in this area.
More Related Videos
07:40Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Inotropic Agents
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease V: Interprofessional Care